Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma uri icon

resumo

  • We thank John Gill for writing and editorial support.

autores

  • RUI MANUEL VIEIRA REIS
  • Butowski, N.
  • Nicole, Angelina
  • Chang, S.M.
  • Sneed, Patricia K.
  • Clarke, Jennifer
  • Lamborn, K.R.
  • Hsieh, Emily
  • Polley, M.-Y.
  • Costa, Bruno Marques
  • Pieper, R.
  • Costello, J.F.
  • Reis, R. M.
  • Butowski, Nicholas
  • Vandenberg, S.
  • Aksoy-Aksel, A.
  • Hristova-Kazmierski, Maria
  • Nicol, Steven J.
  • Thornton, Donald E.
  • Prados, Michael D.
  • Chang, Susan M.
  • Lamborn, Kathleen R.
  • Polley, Mei-Yin
  • Pieper, Russel
  • Costello, Joseph F
  • Vandenberg, Scott
  • Parvataneni, Rupa

data de publicação

  • janeiro 1, 2011